| scholarly article | Q13442814 |
| P2093 | author name string | Charles-Edouard Luyt | |
| Jean Chastre | |||
| Jean-Yves Fagon | |||
| P2860 | cites work | Ventilator-associated pneumonia | Q28212947 |
| The Radiologic Diagnosis of Autopsyproven Ventilator-associated Pneumonia | Q33277933 | ||
| Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription | Q33912931 | ||
| Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients | Q34052619 | ||
| Antibiotic resistance in the intensive care unit | Q34142557 | ||
| Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies | Q35532816 | ||
| Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia | Q40698893 | ||
| Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy | Q40704822 | ||
| Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial | Q42624106 | ||
| Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia | Q44126914 | ||
| Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid | Q44492283 | ||
| Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia | Q51587843 | ||
| Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability | Q51810481 | ||
| Ventilator-associated pneumonia in patients with adult respiratory distress syndrome: CT evaluation | Q52903470 | ||
| Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: a meta-analysis | Q54070888 | ||
| The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia | Q57238120 | ||
| Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals | Q64131543 | ||
| Complications of assisted ventilation. A prospective study of 354 consecutive episodes | Q69798637 | ||
| Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients | Q70414345 | ||
| Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group | Q71510515 | ||
| Indications for antibiotic use in ICU patients: a one-year prospective surveillance | Q73328455 | ||
| Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited | Q73372258 | ||
| Implementation of Bronchoscopic Techniques in the Diagnosis of Ventilator-associated Pneumonia to Reduce Antibiotic Use | Q73977435 | ||
| The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia | Q74304398 | ||
| Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study | Q74598347 | ||
| Pulmonary infiltrates in the surgical ICU: prospective assessment of predictors of etiology and mortality | Q77477740 | ||
| P433 | issue | 5 | |
| P921 | main subject | ventilator | Q813243 |
| P304 | page(s) | 844-852 | |
| P577 | publication date | 2004-02-04 | |
| P1433 | published in | Intensive Care Medicine | Q15749164 |
| P1476 | title | Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia | |
| P478 | volume | 30 |
| Q53787592 | A five year audit of ventilator-associated pneumonia: trends, organisms, antibiotic therapy and admission specialties. |
| Q35489569 | A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia |
| Q57237937 | Advances in lower respiratory tract infections in critically ill patients |
| Q37855009 | Biomarkers for ventilator-associated pneumonia: Review of the literature |
| Q36070410 | C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. |
| Q38835029 | Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit? |
| Q35834622 | Clinical utility of rapid pathogen identification using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in ventilated patients with pneumonia: A pilot study |
| Q34999361 | Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]. |
| Q36116817 | Comparison between a clinical diagnosis method and the surveillance technique of the Center for Disease Control and Prevention for identification of mechanical ventilator-associated pneumonia |
| Q80430065 | De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate |
| Q33612722 | Death by acid rain: VAP or EXIT? |
| Q33653197 | Defining ventilator-associated pneumonia: a (de)construction concept |
| Q37319452 | Defining, treating and preventing hospital acquired pneumonia: European perspective |
| Q61757070 | Diagnose und Therapie der Sepsis |
| Q44754456 | Diagnosis and therapy of sepsis |
| Q36749132 | Diagnosis of ventilator-associated pneumonia: a systematic review of the literature |
| Q37922296 | Diagnosis of ventilator-associated respiratory infections (VARI): microbiologic clues for tracheobronchitis (VAT) and pneumonia (VAP). |
| Q40253807 | Diagnostic Efficacy of Serum Amyloid A Protein and Soluble Intercellular Adhesion Molecule 1 in Pediatric Ventilator-Associated Pneumonia |
| Q79832261 | Does invasive diagnosis of nosocomial pneumonia during off-hours delay treatment? |
| Q40320445 | Early bronchoalveolar lavage for intubated trauma patients with TBI or chest trauma. |
| Q34404666 | Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment |
| Q38394222 | Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial |
| Q41585589 | Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India |
| Q37771799 | Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind. |
| Q48013287 | Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia |
| Q37150599 | Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. |
| Q37643662 | Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia |
| Q42275806 | Impact of the initiation time of colistin treatment for Acinetobacter infections |
| Q39382290 | Intubated Trauma Patients Receiving Prolonged Antibiotics for Pneumonia despite Negative Cultures: Predictors and Outcomes |
| Q38058355 | Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens |
| Q38018983 | Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy. |
| Q33539217 | Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score |
| Q37635443 | No Decrease in Early Ventilator-Associated Pneumonia After Early Use of Chlorhexidine |
| Q41735229 | Predictors of nosocomial pneumonia in intracerebral hemorrhage patients: a multi-center observational study |
| Q33974292 | Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine |
| Q61757039 | Prävention, Diagnose, Therapie und Nachsorge der Sepsis |
| Q33433721 | Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report |
| Q35913456 | Serum procalcitonin: Early detection of neonatal bacteremia and septicemia in a tertiary healthcare facility |
| Q35608519 | Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) as a Diagnostic Marker of Ventilator-Associated Pneumonia |
| Q57779747 | The Impact of Qualitative Respiratory Cultures on Mortality in Critically III Patients with Hospital-Acquired Pneumonia |
| Q37329717 | The utility of the clinical pulmonary infection score |
| Q81109888 | Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia |
| Q51947504 | Validation of an algorithm based on direct examination of specimens in suspected ventilator-associated pneumonia |
| Q58929221 | Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients |
| Q38012082 | Ventilator-Associated Pneumonia: A Comprehensive Review |
| Q90209497 | Ventilator-associated pneumonia in adults: a narrative review |
| Q36541263 | Ventilator-associated pneumonia: a review |
| Q38271775 | Ventilator-associated pneumonia: present understanding and ongoing debates |
| Q35988821 | Year in review in intensive care medicine, 2004. I. Respiratory failure, infection, and sepsis |
Search more.